K. Olgaard
AuthID: R-00F-F6S
1
TITLE: Cinacalcet HCI is an effective primary therapy for the management of secondary hyperparathyroidism (HPT).
AUTHORS: Goodman, WG; Fadda, GZ; Finkelstein, FO; Mittman, N; Lien, YH; Leblanc, M; Locatelli, F; Frazao, JM ; Olgaard, K; Olson, KA; McCary, LC; Turner, SA; Quarles, LD;
PUBLISHED: 2003, SOURCE: 36th Annual Meeting of the American-Society-of-Nephrology in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, VOLUME: 14
AUTHORS: Goodman, WG; Fadda, GZ; Finkelstein, FO; Mittman, N; Lien, YH; Leblanc, M; Locatelli, F; Frazao, JM ; Olgaard, K; Olson, KA; McCary, LC; Turner, SA; Quarles, LD;
PUBLISHED: 2003, SOURCE: 36th Annual Meeting of the American-Society-of-Nephrology in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, VOLUME: 14
INDEXED IN: 
WOS
WOS